"Willkommen im Sana-Herzzentrum Cottbus - bei uns ist Ihr Herz in guten Händen! Seit 1995 werden Patienten im Sana-Herzzentrum, mit Standort in Cottbus, behandelt. Über 60.000 Patienten konnte das Team, bestehend aus Ärzten und Pflegern, seit der ersten Operation am 7. Juni 1995 behandeln. Über 30.000 davon wurden erfolgreich am offenen Herzen operiert. Im Sana-Herzzentrum Cottbus werden Patienten in den Bereichen Herzchirurgie und Kardiologie betreut. Außerdem steht Ihnen kompetentes Fachpersonal in den Bereichen Anästhesie und Pflege zur Verfügung."

During the past decade, Sana-Herzzentrum Cottbus GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sana-Herzzentrum Cottbus GmbH" #1 sponsor was "Medtronic Cardiovascular" with 2 trials, followed by "Symetis SA" with 2 trials sponsored, "Deutsches Herzzentrum Muenchen" with 1 trials sponsored, "IHF GmbH - Institut für Herzinfarktforschung" with 1 trials sponsored and "Medtronic Bakken Research Center" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sana-Herzzentrum Cottbus GmbH" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sana-Herzzentrum Cottbus GmbH" are "Aortic Valve Stenosis" (3 trials), "Aortic Stenosis" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials) and "Coronary Artery Stenosis" (1 trials). Many other conditions were trialed in "Sana-Herzzentrum Cottbus GmbH" in a lesser frequency.

Most popular intervention types in "Sana-Herzzentrum Cottbus GmbH" are "Device" (6 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "ABSORB Scaffold" (1 trials), "ACURATE TA™ Transapical Aortic Bioprosthesis" (1 trials), "ACURATE neo™ Aortic Bioprosthesis" (1 trials), "Aspirin" (1 trials) and "CoreValve Transcatheter Valve" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sana-Herzzentrum Cottbus GmbH" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Sana-Herzzentrum Cottbus GmbH". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sana-Herzzentrum Cottbus GmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sana-Herzzentrum Cottbus GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".